Literature DB >> 26918878

Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.

Alberto Quaglia1, Venancio A Alves2, Charles Balabaud3, Prithi S Bhathal4, Paulette Bioulac-Sage5, James M Crawford6, Amar P Dhillon7, Linda Ferrell8, Maria Guido9, Prodromos Hytiroglou10, Yasuni Nakanuma11, Valerie Paradis12, Dale C Snover13, Neil D Theise14, Swan N Thung15, Wilson M S Tsui16, Dirk J van Leeuwen17,18.   

Abstract

Clinicopathological concepts on acute and chronic liver disease have evolved rapidly during the last few years, with advances in general and specific treatment options and improved patient outcomes. The old paradigm of 'irreversibility' of cirrhosis had been challenged in major ways, and the validity of the usage of the term 'cirrhosis' has come into question. This paper addresses aetiology-based clinicopathological concepts and features that may deserve attention because they may determine disease outcome and, specifically, patterns of regression and remodelling. A variety of therapeutic interventions may influence remaining disease features after elimination of damaging agents (virus, alcohol, etc.), and determine the final clinical outcome including the risk of hepatocellular carcinoma (HCC). New concepts create new responsibilities and opportunities for the pathologist to contribute to the understanding of liver pathology and communicate this with clinical colleagues and researchers.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  biopsy; end stage liver disease; fibrosis; liver cirrhosis; liver regeneration

Mesh:

Year:  2016        PMID: 26918878     DOI: 10.1111/his.12957

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

Authors:  Prodromos Hytiroglou; Neil D Theise
Journal:  Virchows Arch       Date:  2018-03-27       Impact factor: 4.064

2.  Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Subin Heo; Dong Wook Kim; Sang Hyun Choi; Seong Woo Kim; Jong Keon Jang
Journal:  Eur Radiol       Date:  2022-01-19       Impact factor: 5.315

3.  Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.

Authors:  Qiang Li; Xiaojing Ren; Chuan Lu; Weixia Li; Yuxian Huang; Liang Chen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection.

Authors:  Qiang Li; Chuan Lu; Weixia Li; Yuxian Huang; Liang Chen
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

5.  The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.

Authors:  Qiang Li; Chuan Lu; Weixia Li; Yuxian Huang; Liang Chen
Journal:  Oncotarget       Date:  2017-04-25

6.  Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study.

Authors:  Åsa D Borssén; Richard Palmqvist; Stergios Kechagias; Hanns-Ulrich Marschall; Annika Bergquist; Fredrik Rorsman; Ola Weiland; Hans Verbaan; Nils Nyhlin; Emma Nilsson; Mårten Werner
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India.

Authors:  Sumit Rungta; Shweta Kumari; Kamlendra Verma; Ghulam Akhtar; Amar Deep; Suchit Swaroop
Journal:  Cureus       Date:  2021-11-07

8.  ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.

Authors:  Baitong Wu; Jiuxing Feng; Jingyi Guo; Jian Wang; Guanghui Xiu; Jiaqi Xu; Ke Ning; Bin Ling; Qingchun Fu; Jun Xu
Journal:  Stem Cell Res Ther       Date:  2022-10-04       Impact factor: 8.079

9.  Strategies for a Successful Anatomic Pathology Subspecialty Workgroup: The 26-Year Collaboration of "The Elves".

Authors: 
Journal:  Acad Pathol       Date:  2016-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.